Champions Oncology, Inc. (CSBR) Insider Trading Activity

NASDAQ$4.705
Market Cap
$65.49M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
491 of 843
Rank in Industry
286 of 489

CSBR Insider Trading Activity

CSBR Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Champions Oncology, Inc.

Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice. Utilizing this proprietary platform, the company not only delivers personalized cancer solutions directly but also provides Translational Oncology Solutions, supporting pharmaceutical and biotechnology companies through their drug development lifecycle. Additionally, Champions Oncology offers Lumin Bioinformatics, a comprehensive software platform and data tool filled with insights from research services and clinical studies, accessible through annual subscriptions. The company distributes its offerings through various channels, including online platforms, word-of-mouth referrals, and a dedicated sales team, reaching both patients and healthcare professionals. Established in 1985, Champions Oncology, Inc. is based in Hackensack, New Jersey, and was formerly known as Champions Biotechnology, Inc. until its name change in April 2011.

Insider Activity of Champions Oncology, Inc.

Over the last 12 months, insiders at Champions Oncology, Inc. have bought $0 and sold $0 worth of Champions Oncology, Inc. stock.

On average, over the past 5 years, insiders at Champions Oncology, Inc. have bought $245,869 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,000 shares for transaction amount of $6,500 was made by Mendelson Daniel Newman (director) on 2024‑01‑12.

List of Insider Buy and Sell Transactions, Champions Oncology, Inc.

2024-01-12PurchaseMendelson Daniel Newmandirector
1,000
0.0071%
$6.50
$6,500
-27.12%
2024-01-11PurchaseMendelson Daniel Newmandirector
2,000
0.0147%
$6.27
$12,540
-21.18%
2024-01-10PurchaseMendelson Daniel Newmandirector
2,944
0.022%
$6.31
$18,577
-20.33%
2024-01-09PurchaseMendelson Daniel Newmandirector
3,000
0.0221%
$6.25
$18,750
-21.47%
2024-01-08PurchaseMendelson Daniel Newmandirector
1,000
0.0074%
$6.15
$6,150
-20.20%
2024-01-05PurchaseMendelson Daniel Newmandirector
2,000
0.0146%
$6.09
$12,180
-19.22%
2024-01-04PurchaseMendelson Daniel Newmandirector
3,000
0.0221%
$6.12
$18,360
-19.67%
2024-01-03PurchaseMendelson Daniel Newmandirector
500
0.0035%
$5.83
$2,915
-20.33%
2023-12-21PurchaseMendelson Daniel Newmandirector
2,500
0.0184%
$4.92
$12,300
-0.20%
2023-12-20PurchaseMendelson Daniel Newmandirector
2,100
0.015%
$4.82
$10,122
-1.41%
2023-12-19PurchaseMendelson Daniel Newmandirector
5,000
0.0384%
$4.75
$23,750
+7.46%
2023-10-11PurchaseMendelson Daniel Newmandirector
5,000
0.0385%
$6.40
$32,000
-18.72%
2023-10-10PurchaseMendelson Daniel Newmandirector
1,100
0.008%
$6.41
$7,051
-21.44%
2023-10-06PurchaseMendelson Daniel Newmandirector
1,530
0.0114%
$6.48
$9,914
-22.02%
2023-10-05PurchaseMendelson Daniel Newmandirector
2,000
0.0156%
$6.47
$12,940
-18.87%
2023-10-04PurchaseMendelson Daniel Newmandirector
5,000
0.0386%
$6.40
$32,000
-20.16%
2023-10-03PurchaseMendelson Daniel Newmandirector
2,500
0.019%
$6.30
$15,750
-19.75%
2023-09-29PurchaseMendelson Daniel Newmandirector
4,000
0.0294%
$6.16
$24,640
-18.68%
2023-09-28PurchaseMendelson Daniel Newmandirector
5,000
0.0379%
$6.22
$31,100
-16.94%
2023-09-27PurchaseMendelson Daniel Newmandirector
1,500
0.0115%
$5.95
$8,925
-12.63%
Total: 76

Insider Historical Profitability

42.19%
BROWN MICHAEL MAURICE10 percent owner
22281040
160.0814%
$104.83M20
Battery Ventures IX, L.P.10 percent owner
22281040
160.0814%
$104.83M20
Martell Jamesdirector
2051828
14.7417%
$9.65M07
New Enterprise Associates 14, L.P.10 percent owner
1713720
12.3125%
$8.06M01
ACKERMAN JOELdirector
1021731
7.3408%
$4.81M101
+66.05%
Morris RonnieCEO
858878
6.1707%
$4.04M161
+86.37%
Mendelson Daniel Newmandirector
198625
1.4271%
$934,530.63302
<0.0001%
BURKETT DOUGLAS DPresident
850
0.0061%
$3,999.2530
Breitfeld Philip P.director
0
0%
$001

Historical Insider Profitability vs. Competitors

$5,831,763
118
-33.78%
$61.75M
$9,405,928
107
12.61%
$69.86M
$17,525,882
60
5.22%
$62.7M
$103,288,323
51
4.78%
$61.16M
$66,137,559
49
6.29%
$70.03M
$77,146,704
43
13.28%
$77.85M
Champions Oncology, Inc.
(CSBR)
$909,129
37
42.19%
$65.49M
$115,646,156
35
16.45%
$59.08M
$1,602,584
20
15.26%
$68.66M
$3,606,967
19
9.60%
$67.1M
$11,267,080
15
-22.36%
$64.65M
$13,919,584
9
-30.43%
$64.74M
$106,599,960
6
-7.63%
$67.73M
$110,013
5
6.58%
$73.42M
$401,951
4
57.41%
$59.76M
$762,555
4
-34.52%
$70.85M
$67,369,250
3
-22.09%
$62.14M
$110,261
3
-45.30%
$58.49M
$4,030
1
9.14%
$74.15M

CSBR Institutional Investors: Active Positions

Increased Positions10+31.25%154,844+2.7%
Decreased Positions11-34.38%129,728-2.27%
New Positions3New98,744New
Sold Out Positions4Sold Out105,251Sold Out
Total Postitions31-3.13%6M+0.44%

CSBR Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Battery Management Corp.$16,128.0017.3%2.42M00%2025-09-30
Nea Management Company, Llc$11,413.0012.24%1.71M00%2025-09-30
Vanguard Group Inc$2,219.002.38%333,258+6,229+1.91%2025-09-30
Tocqueville Asset Management L.P.$2,129.002.28%319,674-80,208-20.06%2025-09-30
Morgan Stanley$1,263.001.35%189,600+59,100+45.29%2025-09-30
Renaissance Technologies Llc$1,114.001.2%167,261-13,778-7.61%2025-09-30
Blackrock, Inc.$812.000.87%121,910+1,081+0.9%2025-09-30
Geode Capital Management, Llc$496.000.53%74,409-776-1.03%2025-09-30
Northern Trust Corp$309.000.33%46,434-7,328-13.63%2025-09-30
Acadian Asset Management Llc$241.000.26%36,18200%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.